DAVID E I PYOTT Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DAVID E I PYOTT.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DAVID E I PYOTT. DAVID E I PYOTT is Chairman of the Board and CEO in ALLERGAN INC ($AGN) and Director in Avery Dennison Corp ($AVY) and Director in BIOMARIN PHARMACEUTICAL INC ($BMRN) and Director in ALNYLAM PHARMACEUTICALS, INC. ($ALNY) and Director in PLIANT THERAPEUTICS, INC. ($PLRX).
Latest Insider Trading Transactions of DAVID E I PYOTT
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AGN, ALNY, AVY, BMRN, PLRX
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 13 2021 | PLRX | PLIANT THERAPEUTIC ... | PYOTT DAVID E I | Director | Option Exercise | A | 27.71 | 26,573 | 736,338 | 26,573 | |
Sep 01 2020 | BMRN | BIOMARIN PHARMACEU ... | PYOTT DAVID E I | Director | Buy | P | 78.84 | 900 | 70,955 | 30,740 | 29.8 K to 30.7 K (+3.02 %) |
Sep 01 2020 | BMRN | BIOMARIN PHARMACEU ... | PYOTT DAVID E I | Director | Buy | P | 78.22 | 11,900 | 930,760 | 29,840 | 17.9 K to 29.8 K (+66.33 %) |
Sep 01 2020 | BMRN | BIOMARIN PHARMACEU ... | PYOTT DAVID E I | Director | Buy | P | 78.84 | 900 | 70,955 | 30,740 | 29.8 K to 30.7 K (+3.02 %) |
Sep 01 2020 | BMRN | BIOMARIN PHARMACEU ... | PYOTT DAVID E I | Director | Buy | P | 78.22 | 11,900 | 930,760 | 29,840 | 17.9 K to 29.8 K (+66.33 %) |
Jul 06 2020 | ALNY | ALNYLAM PHARMACEUT ... | PYOTT DAVID E I | Director | Option Exercise | A | 148.77 | 4,581 | 681,515 | 4,581 | |
Jul 06 2020 | ALNY | ALNYLAM PHARMACEUT ... | PYOTT DAVID E I | Director | Option Exercise | A | 148.77 | 4,581 | 681,515 | 4,581 | |
May 29 2020 | BMRN | BIOMARIN PHARMACEU ... | PYOTT DAVID E I | Director | Grant | A | 0.00 | 4,300 | 0 | 17,940 | 13.6 K to 17.9 K (+31.52 %) |
Apr 24 2020 | AVY | Avery Dennison Cor ... | PYOTT DAVID E I | Director | Option Exercise | M | 0.00 | 1,414 | 0 | 0 | |
Apr 24 2020 | AVY | Avery Dennison Cor ... | PYOTT DAVID E I | Director | Buy | M | 107.56 | 1,414 | 152,090 | 18,684 | 17.3 K to 18.7 K (+8.19 %) |
Feb 05 2020 | AVY | Avery Dennison Cor ... | PYOTT DAVID E I | Director | Option Exercise | M | 38.18 | 5,027 | 191,931 | 0 | |
Feb 05 2020 | AVY | Avery Dennison Cor ... | PYOTT DAVID E I | Director | Sell | S | 132.72 | 5,027 | 667,183 | 17,270 | 22.3 K to 17.3 K (-22.55 %) |
Feb 05 2020 | AVY | Avery Dennison Cor ... | PYOTT DAVID E I | Director | Buy | M | 38.18 | 5,027 | 191,931 | 22,297 | 17.3 K to 22.3 K (+29.11 %) |
Jul 02 2019 | ALNY | ALNYLAM PHARMACEUT ... | PYOTT DAVID E I | Director | Option Exercise | A | 72.01 | 9,000 | 648,090 | 9,000 | |
Jun 06 2019 | BMRN | BIOMARIN PHARMACEU ... | PYOTT DAVID E I | Director | Grant | A | 0.00 | 4,430 | 0 | 13,640 | 9.2 K to 13.6 K (+48.10 %) |
May 02 2019 | AVY | Avery Dennison Cor ... | PYOTT DAVID E I | Director | Option Exercise | A | 0.00 | 1,414 | 0 | 1,414 | |
May 02 2019 | AVY | Avery Dennison Cor ... | PYOTT DAVID E I | Director | Option Exercise | M | 0.00 | 1,336 | 0 | 0 | |
May 02 2019 | AVY | Avery Dennison Cor ... | PYOTT DAVID E I | Director | Option Exercise | M | 0.00 | 641 | 0 | 0 | |
May 02 2019 | AVY | Avery Dennison Cor ... | PYOTT DAVID E I | Director | Buy | M | 109.63 | 1,336 | 146,466 | 17,270 | 15.9 K to 17.3 K (+8.38 %) |
May 02 2019 | AVY | Avery Dennison Cor ... | PYOTT DAVID E I | Director | Buy | M | 109.63 | 641 | 70,273 | 15,934 | 15.3 K to 15.9 K (+4.19 %) |
Nov 28 2018 | AVY | Avery Dennison Cor ... | PYOTT DAVID E I | Director | Option Exercise | M | 20.64 | 2,000 | 41,280 | 0 | |
Nov 28 2018 | AVY | Avery Dennison Cor ... | PYOTT DAVID E I | Director | Sell | S | 93.00 | 2,000 | 186,000 | 15,293 | 17.3 K to 15.3 K (-11.57 %) |
Nov 28 2018 | AVY | Avery Dennison Cor ... | PYOTT DAVID E I | Director | Buy | M | 20.64 | 2,000 | 41,280 | 17,293 | 15.3 K to 17.3 K (+13.08 %) |
Jun 22 2018 | ALNY | ALNYLAM PHARMACEUT ... | PYOTT DAVID E I | Director | Option Exercise | A | 105.26 | 9,000 | 947,340 | 9,000 | |
Jun 07 2018 | BMRN | BIOMARIN PHARMACEU ... | PYOTT DAVID E I | Director | Grant | A | 0.00 | 4,300 | 0 | 9,210 | 4.9 K to 9.2 K (+87.58 %) |
May 02 2018 | AVY | Avery Dennison Cor ... | PYOTT DAVID E I | Director | Option Exercise | A | 0.00 | 1,336 | 0 | 1,336 | |
May 02 2018 | AVY | Avery Dennison Cor ... | PYOTT DAVID E I | Director | Option Exercise | M | 0.00 | 1,678 | 0 | 0 | |
May 02 2018 | AVY | Avery Dennison Cor ... | PYOTT DAVID E I | Director | Option Exercise | M | 0.00 | 641 | 0 | 641 | |
May 02 2018 | AVY | Avery Dennison Cor ... | PYOTT DAVID E I | Director | Option Exercise | M | 0.00 | 747 | 0 | 0 | |
May 02 2018 | AVY | Avery Dennison Cor ... | PYOTT DAVID E I | Director | Buy | M | 104.80 | 1,678 | 175,854 | 15,293 | 13.6 K to 15.3 K (+12.32 %) |
May 02 2018 | AVY | Avery Dennison Cor ... | PYOTT DAVID E I | Director | Buy | M | 104.80 | 641 | 67,177 | 13,615 | 13 K to 13.6 K (+4.94 %) |
May 02 2018 | AVY | Avery Dennison Cor ... | PYOTT DAVID E I | Director | Buy | M | 104.80 | 747 | 78,286 | 12,974 | 12.2 K to 13 K (+6.11 %) |
Aug 30 2017 | AVY | Avery Dennison Cor ... | PYOTT DAVID E I | Director | Option Exercise | M | 52.12 | 1,702 | 88,700 | 0 | |
Aug 30 2017 | AVY | Avery Dennison Cor ... | PYOTT DAVID E I | Director | Option Exercise | M | 52.12 | 298 | 15,530 | 1,702 | |
Aug 30 2017 | AVY | Avery Dennison Cor ... | PYOTT DAVID E I | Director | Sell | S | 94.00 | 1,702 | 159,988 | 16,303 | 18 K to 16.3 K (-9.45 %) |
Aug 30 2017 | AVY | Avery Dennison Cor ... | PYOTT DAVID E I | Director | Buy | M | 52.12 | 1,702 | 88,700 | 18,005 | 16.3 K to 18 K (+10.44 %) |
Aug 30 2017 | AVY | Avery Dennison Cor ... | PYOTT DAVID E I | Director | Sell | S | 94.00 | 298 | 28,012 | 16,303 | 16.6 K to 16.3 K (-1.80 %) |
Aug 30 2017 | AVY | Avery Dennison Cor ... | PYOTT DAVID E I | Director | Buy | M | 52.12 | 298 | 15,530 | 16,601 | 16.3 K to 16.6 K (+1.83 %) |
Jun 08 2017 | BMRN | BIOMARIN PHARMACEU ... | PYOTT DAVID E I | Director | Option Exercise | A | 89.60 | 4,910 | 439,936 | 4,910 | |
Jun 08 2017 | BMRN | BIOMARIN PHARMACEU ... | PYOTT DAVID E I | Director | Grant | A | 0.00 | 2,050 | 0 | 4,910 | 2.9 K to 4.9 K (+71.68 %) |
Jun 06 2017 | ALNY | ALNYLAM PHARMACEUT ... | PYOTT DAVID E I | Director | Option Exercise | A | 71.99 | 11,250 | 809,888 | 11,250 | |
May 03 2017 | AVY | Avery Dennison Cor ... | PYOTT DAVID E I | Director | Option Exercise | A | 0.00 | 1,678 | 0 | 1,678 | |
May 03 2017 | AVY | Avery Dennison Cor ... | PYOTT DAVID E I | Director | Option Exercise | M | 0.00 | 640 | 0 | 1,282 | |
May 03 2017 | AVY | Avery Dennison Cor ... | PYOTT DAVID E I | Director | Option Exercise | M | 0.00 | 746 | 0 | 747 | |
May 03 2017 | AVY | Avery Dennison Cor ... | PYOTT DAVID E I | Director | Option Exercise | M | 0.00 | 859 | 0 | 0 | |
May 03 2017 | AVY | Avery Dennison Cor ... | PYOTT DAVID E I | Director | Buy | M | 83.42 | 640 | 53,389 | 16,303 | 15.7 K to 16.3 K (+4.09 %) |
May 03 2017 | AVY | Avery Dennison Cor ... | PYOTT DAVID E I | Director | Buy | M | 83.42 | 746 | 62,231 | 15,663 | 14.9 K to 15.7 K (+5.00 %) |
May 03 2017 | AVY | Avery Dennison Cor ... | PYOTT DAVID E I | Director | Buy | M | 83.42 | 859 | 71,658 | 14,917 | 14.1 K to 14.9 K (+6.11 %) |
Oct 14 2016 | ALNY | ALNYLAM PHARMACEUT ... | PYOTT DAVID E I | Director | Buy | P | 37.00 | 27,900 | 1,032,328 | 27,900 | 0 to 27.9 K |
Aug 09 2016 | AVY | Avery Dennison Cor ... | PYOTT DAVID E I | Director | Option Exercise | M | 67.80 | 2,000 | 135,590 | 0 | |
Aug 09 2016 | AVY | Avery Dennison Cor ... | PYOTT DAVID E I | Director | Sell | S | 78.61 | 2,000 | 157,220 | 14,058 | 16.1 K to 14.1 K (-12.45 %) |
Aug 09 2016 | AVY | Avery Dennison Cor ... | PYOTT DAVID E I | Director | Buy | M | 67.80 | 2,000 | 135,590 | 16,058 | 14.1 K to 16.1 K (+14.23 %) |
Jun 08 2016 | BMRN | BIOMARIN PHARMACEU ... | PYOTT DAVID E I | Director | Option Exercise | A | 89.52 | 2,220 | 198,734 | 2,220 | |
Jun 08 2016 | BMRN | BIOMARIN PHARMACEU ... | PYOTT DAVID E I | Director | Grant | A | 0.00 | 760 | 0 | 2,860 | 2.1 K to 2.9 K (+36.19 %) |
Jun 07 2016 | ALNY | ALNYLAM PHARMACEUT ... | PYOTT DAVID E I | Director | Option Exercise | A | 70.20 | 11,250 | 789,750 | 11,250 | |
May 02 2016 | AVY | Avery Dennison Cor ... | PYOTT DAVID E I | Director | Option Exercise | A | 0.00 | 1,922 | 0 | 1,922 | |
May 02 2016 | AVY | Avery Dennison Cor ... | PYOTT DAVID E I | Director | Option Exercise | M | 0.00 | 746 | 0 | 1,493 | |
May 02 2016 | AVY | Avery Dennison Cor ... | PYOTT DAVID E I | Director | Option Exercise | M | 0.00 | 859 | 0 | 859 | |
May 02 2016 | AVY | Avery Dennison Cor ... | PYOTT DAVID E I | Director | Option Exercise | M | 0.00 | 1,015 | 0 | 0 | |
May 02 2016 | AVY | Avery Dennison Cor ... | PYOTT DAVID E I | Director | Buy | M | 72.82 | 746 | 54,324 | 14,058 | 13.3 K to 14.1 K (+5.60 %) |
May 02 2016 | AVY | Avery Dennison Cor ... | PYOTT DAVID E I | Director | Buy | M | 72.82 | 859 | 62,552 | 13,312 | 12.5 K to 13.3 K (+6.90 %) |
May 02 2016 | AVY | Avery Dennison Cor ... | PYOTT DAVID E I | Director | Buy | M | 72.82 | 1,015 | 73,912 | 12,453 | 11.4 K to 12.5 K (+8.87 %) |
Jan 06 2016 | BMRN | BIOMARIN PHARMACEU ... | PYOTT DAVID E I | Director | Option Exercise | A | 104.92 | 6,100 | 640,012 | 6,100 | |
Jan 06 2016 | BMRN | BIOMARIN PHARMACEU ... | PYOTT DAVID E I | Director | Grant | A | 0.00 | 2,100 | 0 | 2,100 | 0 to 2.1 K |
Dec 22 2015 | ALNY | ALNYLAM PHARMACEUT ... | PYOTT DAVID E I | Director | Option Exercise | A | 88.95 | 25,000 | 2,223,750 | 25,000 | |
Nov 03 2015 | AVY | Avery Dennison Cor ... | PYOTT DAVID E I | Director | Option Exercise | M | 59.47 | 2,000 | 118,930 | 0 | |
Nov 03 2015 | AVY | Avery Dennison Cor ... | PYOTT DAVID E I | Director | Sell | S | 64.88 | 2,000 | 129,760 | 11,438 | 13.4 K to 11.4 K (-14.88 %) |
Nov 03 2015 | AVY | Avery Dennison Cor ... | PYOTT DAVID E I | Director | Buy | M | 59.47 | 2,000 | 118,930 | 13,438 | 11.4 K to 13.4 K (+17.49 %) |
May 04 2015 | AVY | Avery Dennison Cor ... | PYOTT DAVID E I | Director | Option Exercise | A | 0.00 | 2,239 | 0 | 2,239 | |
May 04 2015 | AVY | Avery Dennison Cor ... | PYOTT DAVID E I | Director | Option Exercise | M | 0.00 | 859 | 0 | 1,718 | |
May 04 2015 | AVY | Avery Dennison Cor ... | PYOTT DAVID E I | Director | Option Exercise | M | 0.00 | 1,015 | 0 | 1,015 | |
May 04 2015 | AVY | Avery Dennison Cor ... | PYOTT DAVID E I | Director | Buy | M | 55.84 | 859 | 47,967 | 11,438 | 10.6 K to 11.4 K (+8.12 %) |
May 04 2015 | AVY | Avery Dennison Cor ... | PYOTT DAVID E I | Director | Buy | M | 55.84 | 1,015 | 56,678 | 10,579 | 9.6 K to 10.6 K (+10.61 %) |
Apr 28 2015 | AVY | Avery Dennison Cor ... | PYOTT DAVID E I | Director | Option Exercise | M | 0.00 | 524 | 0 | 0 | |
Apr 28 2015 | AVY | Avery Dennison Cor ... | PYOTT DAVID E I | Director | Buy | M | 51.77 | 524 | 27,127 | 9,564 | 9 K to 9.6 K (+5.80 %) |
Mar 19 2015 | AGN | ALLERGAN INC | PYOTT DAVID E I | Chairman of the Boa ... | Option Exercise | D | 125.07 | 257,756 | 32,237,543 | 0 | |
Mar 19 2015 | AGN | ALLERGAN INC | PYOTT DAVID E I | Chairman of the Boa ... | Option Exercise | D | 59.13 | 422,400 | 24,976,512 | 0 | |
Mar 19 2015 | AGN | ALLERGAN INC | PYOTT DAVID E I | Chairman of the Boa ... | Option Exercise | D | 105.87 | 303,000 | 32,078,610 | 0 | |
Mar 19 2015 | AGN | ALLERGAN INC | PYOTT DAVID E I | Chairman of the Boa ... | Option Exercise | D | 40.16 | 533,000 | 21,405,280 | 0 | |
Mar 19 2015 | AGN | ALLERGAN INC | PYOTT DAVID E I | Chairman of the Boa ... | Option Exercise | D | 87.91 | 312,000 | 27,427,920 | 0 | |
Mar 19 2015 | AGN | ALLERGAN INC | PYOTT DAVID E I | Chairman of the Boa ... | Option Exercise | D | 75.58 | 375,000 | 28,342,500 | 0 | |
Mar 19 2015 | AGN | ALLERGAN INC | PYOTT DAVID E I | Chairman of the Boa ... | Option Exercise | D | 64.47 | 410,000 | 26,432,700 | 0 | |
Mar 19 2015 | AGN | ALLERGAN INC | PYOTT DAVID E I | Chairman of the Boa ... | Option Exercise | D | 58.55 | 386,800 | 22,647,140 | 0 | |
Mar 19 2015 | AGN | ALLERGAN INC | PYOTT DAVID E I | Chairman of the Boa ... | Sell | D | 0.00 | 114,548 | 0 | 0 | 114.5 K to 0 (-100.00 %) |
Mar 19 2015 | AGN | ALLERGAN INC | PYOTT DAVID E I | Chairman of the Boa ... | Sell | D | 0.00 | 2,897 | 0 | 0 | 2.9 K to 0 (-100.00 %) |
Mar 19 2015 | AGN | ALLERGAN INC | PYOTT DAVID E I | Chairman of the Boa ... | Sell | D | 0.00 | 2,180 | 0 | 0 | 2.2 K to 0 (-100.00 %) |
Mar 19 2015 | AGN | ALLERGAN INC | PYOTT DAVID E I | Chairman of the Boa ... | Sell | D | 0.00 | 165,658 | 0 | 0 | 165.7 K to 0 (-100.00 %) |
Mar 19 2015 | AGN | ALLERGAN INC | PYOTT DAVID E I | Chairman of the Boa ... | Gift | G | 0.00 | 114,548 | 0 | 114,548 | 229.1 K to 114.5 K (-50.00 %) |
Feb 24 2015 | AGN | ALLERGAN INC | PYOTT DAVID E I | Chairman of the Boa ... | Option Exercise | M | 0.00 | 1,379 | 0 | 0 | |
Feb 24 2015 | AGN | ALLERGAN INC | PYOTT DAVID E I | Chairman of the Boa ... | Option Exercise | A | 0.00 | 1,379 | 0 | 1,379 | |
Feb 24 2015 | AGN | ALLERGAN INC | PYOTT DAVID E I | Chairman of the Boa ... | Payment of Exercise | F | 234.00 | 720 | 168,480 | 165,659 | 166.4 K to 165.7 K (-0.43 %) |
Feb 24 2015 | AGN | ALLERGAN INC | PYOTT DAVID E I | Chairman of the Boa ... | Buy | M | 0.00 | 1,379 | 0 | 166,379 | 165 K to 166.4 K (+0.84 %) |
Page: 1